Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

This study has been completed.
Sponsor:
Collaborator:
Onyx Pharmaceuticals
Information provided by (Responsible Party):
Jennifer Woyach, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01212380
First received: September 10, 2010
Last updated: May 6, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)